The “Pain and Cancer” research axis is dedicated to the characterization and physio-pharmacology of pain associated with cancer, including pain linked to cancer metastases and chemo-induced peripheral neuropathies (CIPN). We are also exploring the epidemiology of pain and co-morbidities during and after cancer, as well as the study of predictive biomarkers for CIPN, such as miRNAs and proteins. Our research includes the pathophysiology of CIPN, therapeutic innovation for their treatment and the identification of predictive factors for the evolution of neuropathic pain upon diagnosis of cancer.
Journal articles
2024
2023
2022
2021
2020
2019
Dextromethorphan and memantine after ketamine analgesia: a randomized control trial
. Drug Design, Development and Therapy, 2019, Volume 13, pp.2677-2688. ⟨10.2147/DDDT.S207350⟩. ⟨hal-02325142⟩
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Conference papers
2024
2023
2022
2021
2019
Book sections
2018
2015
Poster communications
2024
2023
2022
2019
2017
Reports
2023
2021
2020
Preprints, Working Papers, …
2022